ZTE, Nokia, and Huawei Lead ABI Research's 5G FWA CPE Vendor Competitive Ranking
LONDON, Jan. 14, 2025 /PRNewswire/ -- A new Competitive Ranking by global technology intelligence firm ABI Research has found that ZTE is the leading 5G FWA CPE vendor, beating both Nokia and Huawei for the top spot overall and across both the...
Argon Medical Expands Oncology Product Offering with Acquisition of the SeQure® and DraKon™ Microcatheters
PLANO, Texas, Jan. 14, 2025 /PRNewswire/ -- Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announces the acquisition of certain assets...
Cognex Strengthens Market Leadership in Industrial Barcode Reading with Two New AI-Powered Products
DataMan 290 and 390 barcode readers, backed by industry-leading customer support, deliver unmatched reliability and ease of use NATICK, Mass., Jan. 14, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the leader in industrial machine vision,...
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
Powered by Android 14 and Qualcomm® Snapdragon™ 6490 Octa-Core Processor, Engineered for Demanding Fleet Applications TAIPEI, Jan. 14, 2025 /PRNewswire/ -- RuggON Corporation proudly introduces the VIKING II, a groundbreaking fleet management device...
IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award
Recognized for brand leadership with its "Timing is Everything" controlled release platform for oral drug delivery. NEW YORK, Jan. 14, 2025 /PRNewswire/ -- IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, announced today...
Korea's Leading Indie Beauty Brand d'Alba, Reaches New Heights Globally with 210% Overseas Sales Surge
SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ -- Premium vegan beauty brand d'Alba has achieved significant growth in its overseas sales, rising to approximately KRW 150 billion won (USD 100 million) in 2024 - which is a 210% growth compared to the...
ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS
SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ -- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for 'Pemziviptadil (development code name PF1804),' a treatment for DMD (Duchenne Muscular Dystrophy)...
DJI Launches All-in-One Vlog Camera Drone with DJI Flip
New DJI Flip is DJI's first drone to feature foldable, full-coverage propeller guards for ultimate flight safety SHENZHEN, China, Jan. 14, 2025 /PRNewswire/ -- DJI, the global leader in civilian drones and creative camera technology, today announces...